Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol (Q68257423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol (English)

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

22 October 2022

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

P. J. Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

C. Kalayci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

N. Dobbs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

N. Raby

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

E. M. Metivier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

L. Summers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

P. Harper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

R. Williams

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655867

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1655867

22 October 2022

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:016882789190873A?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

https://api.elsevier.com/content/article/PII:016882789190873A?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

22 October 2022

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

120-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

A critical evaluation of the principles governing the advantages of intra-arterial infusions

23 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium

22 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Induction of remission in hepatocellular carcinoma with doxorubicin

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Transcatheter arterial chemoembolization for hepatocellular carcinoma

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Transcatheter oily chemoembolization of hepatocellular carcinoma

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma

22 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms

22 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Multimodal treatment of hepatocellular carcinoma

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Hepatocellular carcinoma detected by iodized oil

22 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents

22 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma

22 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Catheter replacement of the needle in percutaneous arteriography; a new technique

22 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Estimation of doxorubicin and doxorubicinol by high-performance liquid chromatography and advanced automated sample processor

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

A pharmacokinetic analysis program (multi) for microcomputer

22 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

STRIPE: an interactive computer program for the analysis of drug pharmacokinetics

22 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

22 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

22 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

22 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Selective effects of lipiodolized antitumor agents

22 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

22 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report

22 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration

22 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Hepatic extraction of adriamycin in patients with hepatocellular carcinoma

22 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

Pharmacology and Clinical Toxicity of 4'-Iodo-4'-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials

22 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90873-A

22 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1655867%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference